Q Fever Market Report – Research, Industry Analysis Reports and Market Demands

Global Q Fever Market Professional Survey Report 2019

Request for Sample of this report

Buy now

Table of Content

Executive Summary

1 Industry Overview of Q Fever

1.1 Definition of Q Fever
1.2 Q Fever Segment by Type
- 1.2.1 Global Q Fever Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Acute Q Fever
- 1.2.3 Chronic Q Fever
1.3 Q Fever Segment by Applications
- 1.3.1 Global Q Fever Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals & Clinics
- 1.3.3 Diagnostic Centers
- 1.3.4 Surgical Centers
1.4 Global Q Fever Overall Market
- 1.4.1 Global Q Fever Revenue (2014-2025)
- 1.4.2 Global Q Fever Production (2014-2025)
- 1.4.3 North America Q Fever Status and Prospect (2014-2025)
- 1.4.4 Europe Q Fever Status and Prospect (2014-2025)
- 1.4.5 China Q Fever Status and Prospect (2014-2025)
- 1.4.6 Japan Q Fever Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Q Fever Status and Prospect (2014-2025)
- 1.4.8 India Q Fever Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Q Fever
2.3 Manufacturing Process Analysis of Q Fever
2.4 Industry Chain Structure of Q Fever

3 Development and Manufacturing Plants Analysis of Q Fever

3.1 Capacity and Commercial Production Date
3.2 Global Q Fever Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Q Fever
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

4.1 Q Fever Production and Capacity Analysis
4.2 Q Fever Revenue Analysis
4.3 Q Fever Price Analysis
4.4 Market Concentration Degree

5 Q Fever Regional Market Analysis

5.1 Q Fever Production by Regions
- 5.1.1 Global Q Fever Production by Regions
- 5.1.2 Global Q Fever Revenue by Regions
5.2 Q Fever Consumption by Regions
5.3 North America Q Fever Market Analysis
- 5.3.1 North America Q Fever Production
- 5.3.2 North America Q Fever Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Q Fever Import and Export
5.4 Europe Q Fever Market Analysis
- 5.4.1 Europe Q Fever Production
- 5.4.2 Europe Q Fever Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Q Fever Import and Export
5.5 China Q Fever Market Analysis
- 5.5.1 China Q Fever Production
- 5.5.2 China Q Fever Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Q Fever Import and Export
5.6 Japan Q Fever Market Analysis
- 5.6.1 Japan Q Fever Production
- 5.6.2 Japan Q Fever Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Q Fever Import and Export
5.7 Southeast Asia Q Fever Market Analysis
- 5.7.1 Southeast Asia Q Fever Production
- 5.7.2 Southeast Asia Q Fever Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Q Fever Import and Export
5.8 India Q Fever Market Analysis
- 5.8.1 India Q Fever Production
- 5.8.2 India Q Fever Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Q Fever Import and Export

6 Q Fever Segment Market Analysis (by Type)

6.1 Global Q Fever Production by Type
6.2 Global Q Fever Revenue by Type
6.3 Q Fever Price by Type

7 Q Fever Segment Market Analysis (by Application)

7.1 Global Q Fever Consumption by Application
7.2 Global Q Fever Consumption Market Share by Application (2014-2019)

8 Q Fever Major Manufacturers Analysis

9 Development Trend of Analysis of Q Fever Market

9.1 Global Q Fever Market Trend Analysis
- 9.1.1 Global Q Fever Market Size (Volume and Value) Forecast 2019-2025
9.2 Q Fever Regional Market Trend
- 9.2.1 North America Q Fever Forecast 2019-2025
- 9.2.2 Europe Q Fever Forecast 2019-2025
- 9.2.3 China Q Fever Forecast 2019-2025
- 9.2.4 Japan Q Fever Forecast 2019-2025
- 9.2.5 Southeast Asia Q Fever Forecast 2019-2025
- 9.2.6 India Q Fever Forecast 2019-2025
9.3 Q Fever Market Trend (Product Type)
9.4 Q Fever Market Trend (Application)
10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
10.3 Q Fever Customers

11 Market Dynamics

11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion

13 Appendix

13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
13.3 Author List

Description

Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases.

The global Q Fever market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Q Fever volume and value at global level, regional level and company level. From a global perspective, this report represents overall Q Fever market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Q Fever in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Q Fever manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (US)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
MELINTA THERAPEUTICS, INC. (US)
Pfizer (US)
Cipla Inc. (India)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Acute Q Fever
Chronic Q Fever

Segment by Application
Hospitals & Clinics
Diagnostic Centers
Surgical Centers